CPI Enterprises portfolio updates – February 2025
What have our CPI Enterprises portfolio companies been up to in 2025? What investments has CPI Enterprises made this year? Matthew McCann details all.
Investor Relationships Manager
(he/him)
From BBC News to The Startups 100 Index to the Engineering Innovator of the Year award, our portfolio companies have had a busy and successful start to 2025.
What highlights did our portfolio companies have in the second half of 2024? Matthew McCann details how they finished the year strong.
From groundbreaking funding rounds to prestigious awards and strategic partnerships, the latter half of 2024 brought a period of remarkable achievements and progress for our portfolio companies, showcasing their impact across sustainability, healthcare innovation, advanced manufacturing, and more.
July
The Coalition for Epidemic Preparedness Innovations (CEPI) announced $320,000 of funding for BiologIC Technologies to explore the development of mRNA vaccine platforms that can use AI to more quickly and easily produce mRNA vaccines locally to contain disease outbreaks. Also in July, the UK Space Agency (UKSA) announced that BiologIC Technologies will share a £65m fund to adapt its bioprocessing platform for operation in microgravity, which will be tested on the International Space Station.
Graphene Composites was selected to participate in an R&D program with DEVCOM Soldier Center, Natick MA and UMass Lowell to develop materials for next-generation US military footwear that can withstand extreme cold weather using Graphene Composites’ graphene and aerogel technology.
August
QV Bioelectronics received £343,000 funding from Innovate UK’s Cancer Therapeutics programme to translate their electric field therapy device from adult to childhood brain cancer, involving device development and preclinical testing.
Q5D Technologies appointed Scott White, former CEO of Pragmatic Semiconductor, as Chair of its board, marking a significant step in its growth trajectory.
September
Evoralis secured follow-on investment of £2.5 million in a seed funding round to transform textile and plastic recycling, converting CPI Enterprises’ previous convertible loan investment into equity.
Q5D announced the delivery of its CY10W robotic wire harness manufacturing platform to MTC in Coventry and the achievement of CE marking, which is the first step towards a pilot production line.
QV Bioelectronics announced breakthrough pre-clinical safety and efficacy results for its electric field therapy device for glioblastoma treatment. These results pave the way for first-in-human trials.
October
Floreon’s Therma-Tech bioplastic won the Innovation in Bioplastics Award at the US Plastics Industry Association Awards, recognising its far-reaching potential across multiple global industries.
Graphene Composites was granted a patent from the UK’s IPO for its GC Halo technology – a graphene ink that can destroy pathogens.
November
DEScycle closed a £10.2 million Series A funding round led by BGF to scale its metal recycling technology, with participation from Cisco Investments and other notable investors.
Q5D won the Manufacturing Innovation prize at the Robotics and Automation Awards for its CY1000 wiring automation robot.
December
Qkine partnered with Culturon (Sydney, Australia) to deliver cutting-edge solutions for the stem cell and life sciences industries.
Daniel Peters, CEO of MarraBio, participated in a roundtable session on ‘innovation in agribusiness’. MarraBio is continuing its product development, expanding towards commercial launch.
For more information
Enjoyed this article? Keep reading more expert insights...
CPI ensures that great inventions gets the best opportunity to become a successfully marketed product or process. We provide industry-relevant expertise and assets, supporting proof of concept and scale up services for the development of your innovative products and processes.